AI-based support for lung cancer screening scans
Part of Cancer, Lungs & breathing clinical trials.
This trial tests whether using artificial intelligence (computer pattern-recognition) with lung screening images can help identify people who may have lung cancer earlier. It’s meant for people at higher risk because of their smoking history, who can follow the screening steps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 50 and 80 years old
- You currently smoke or quit within the last 15 years
- You have at least a 20 “pack-year” smoking history
- You can sign the informed consent and are covered by French social security
- Your most recent chest scan (if you had one) was not done in the last year for another reason
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well an AI tool can predict lung cancer risk, based on your health information. It looks at how patients feel about this approach to screening, with the goal of making screening more personal and effective.
This trial tests whether using AI to help radiologists read lung CT scans can find cancer earlier and lower healthcare costs. You may qualify if you are at risk for lung cancer and have not been screened recently.
This study uses an AI computer program to help doctors read low-dose CT scans of the chest to find lung cancer early. It is for people at higher risk due to family history, smoking, or general health check-ups.
This study uses artificial intelligence to analyze lung cancer risk in current or former smokers. It may help find ways to detect lung cancer earlier.
This study tests an artificial intelligence device to screen for lung cancer in people who have never smoked but have a close family member with lung cancer. If you are between 50 and 75 and fit for possible surgery, you may be able to join.
This study tests an artificial intelligence (AI) system that uses your health information and medical images to better judge cancer risk and support diagnosis and treatment decisions. It may help doctors make more consistent assessments by combining clinical records, imaging, and other lab-style data.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.